国际简称:NEUROL THER 参考译名:神经病学和治疗
Aims and Scope
Neurology and Therapy aims to provide reliable and inclusive, rapid publication for all therapy related research for neurological indications, supporting the timely dissemination of research with a global reach, to help advance scientific discovery and support clinical practice.
Neurology and Therapy is an international, open access, peer reviewed, rapid publication journal dedicated to the publication of high-quality clinical (all phases), observational, real-world and health outcomes research around the discovery, development, and use of neurological and psychiatric therapies, (also covering surgery and devices). Studies relating to diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also welcomed.
The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, case reports, trial designs, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Neurology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.
Rapid Publication
The journal’s rapid publication timelines aim for a peer review decision within 2 weeks of submission. If an article is accepted, it will be published online 3-4 weeks from acceptance. These rapid timelines are achieved through the combination of a dedicated in-house editorial team, who closely manage article workflow, and an extensive Editorial and Advisory Board who assist with rapid peer review. This allows the journal to support the rapid dissemination of research, whilst still providing robust peer review. Combined with the journal’s open access model, this allows for the rapid and efficient communication of the latest research and reviews to support scientific discovery and clinical practice.
Open Access
All articles published by Neurology and Therapy are open access.
Personal Service
The journal’s dedicated in-house editorial team offer a personal “concierge service” meaning that authors will always have a personal point of contact able to update them on the status of their manuscript. The editorial team check all manuscripts to ensure that articles conform to the most recent COPE and ICMJE publishing guidelines. This supports the publication of ethically sound and transparent research. We also encourage pre-submission enquiries and are always happy to provide a confidential assessment of manuscripts.
Digital Features and Plain Language Summaries
Neurology and Therapy offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by key summary points, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. If you consider that your paper would benefit from the inclusion of a digital feature, please let us know. Our editorial team are able to create high-quality slide decks and infographics in-house, and video abstracts through our partner Research Square, and would be happy to assist in any way we can. For further information about digital features, please contact the journal editor (see ‘Contact the Journal’ for email address), and see the ‘Guidelines for digital features and plain language summaries’ document under ‘Submission guidelines’.
For examples of digital features please visit our showcase page https://springerhealthcare.com/expertise/publishing-digital-features/
Publication Fees
Upon acceptance of an article, authors will be required to pay the mandatory Rapid Service Fee of €5250/$6000/£4300. The journal will consider fee discounts and waivers for developing countries and this is decided on a case-by-case basis.
Peer Review Process
Upon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive single-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria.
At least two extensive reviews are required to make the editorial decision, with the exception of some article types such as Commentaries, Editorials and Letters which are generally reviewed by one member of the Editorial Board. Where reviews conflict, an Editorial Board Member will be contacted for further advice and a presiding decision. Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed. Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised, it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication. Appeals against decisions following peer review are considered on a case-by-case basis and should be sent to the journal editor, and authors are welcome to make rebuttals against individual reviewer comments, if appropriate.
Preprints
We encourage posting of preprints of primary research manuscripts on preprint servers, authors' or institutional websites, and open communications between researchers whether on community preprint servers or preprint commenting platforms. Posting of preprints is not considered prior publication and will not jeopardize consideration in our journals.
Please see here for further information on preprint sharing: https://www.springer.com/gp/authors-editors/journal-author/journal-author-helpdesk/submission/1302#c16721550
Copyright
Neurology and Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0.
Contact
For more information about the journal, including pre-submission enquiries, please contact managing editor Lydia Alborn at lydia.alborn@springer.com.
《Neurology And Therapy》是一本医学优秀杂志。致力于发表原创科学研究结果,并为医学各个领域的原创研究提供一个展示平台,以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述,从广泛的视角提供当前感兴趣的研究主题的新见解,或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年被列入预警期刊名单,目前已被权威数据库SCI、SCIE收录,得到了广泛的认可。
该期刊投稿重要关注点:
学科类别 | 分区 | 排名 | 百分位 |
大类:Medicine 小类:Neurology (clinical) | Q2 | 134 / 400 |
66% |
大类:Medicine 小类:Neurology | Q2 | 67 / 192 |
65% |
CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础,针对的是前四年发表的论文的引文。CiteScore的意义在于,它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法,而不仅仅是通过影响因子(IF)这一单一指标来评价。
大类学科 | 分区 | 小类学科 | 分区 |
医学 | 3区 | CLINICAL NEUROLOGY 临床神经病学 | 3区 |
大类学科 | 分区 | 小类学科 | 分区 |
医学 | 3区 | CLINICAL NEUROLOGY 临床神经病学 | 3区 |
大类学科 | 分区 | 小类学科 | 分区 |
医学 | 3区 | CLINICAL NEUROLOGY 临床神经病学 | 4区 |
大类学科 | 分区 | 小类学科 | 分区 |
医学 | 2区 | CLINICAL NEUROLOGY 临床神经病学 | 2区 |
大类学科 | 分区 | 小类学科 | 分区 |
医学 | 3区 | CLINICAL NEUROLOGY 临床神经病学 | 4区 |
中科院分区表 是以客观数据为基础,运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据,得到了全国各地高校、科研机构的广泛认可。
中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次,类似于“优、良、及格”等。最开始,这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。
JCR 分区等级 | JCR 学科 | JCR 分区 |
Q1 | CLINICAL NEUROLOGY | Q2 |
JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异,此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此,JCR将期刊按照学科门类和影响因子分为不同的分区,这样读者可以根据自己的研究领域和需求选择合适的期刊。
一般刊物只分省级、国家级、核心,期刊本身是没有几类划分的,具体是几类或者几级,您可以对照单位的分类文件确认一下。Neurology And Therapy杂志是由SPRINGER LONDON LTD出版的一本SCI、SCIE,可用于职称评定。
大多数核心期刊我们都是可以提供咨询服务的。目前核心期刊主要分为以下几类:1.国内核心:按照权威度排序,社科类:南大核心>南大扩展>北大核心>科技核心 按照权威度排序。工科类:CSCD C库>CSCD E库(相当于CSCD扩展)>北大核心>科技核心。2.国外核心(全英文):按照权威度排序为:SSCI=SCI>EI>ISTP=CPCI。
为了确保您的职称评定顺利进行,我们建议提前半年到一年开始准备,这样能够保证有充足的时间来处理所有相关事宜。如果客户需要加急服务,我们会与杂志社进行沟通,以确定是否可以提供加急服务。请注意,如果确认可以加急,可能会收取一定的加急费用。
期刊编辑会综合考虑多个因素,如发表范围、学术价值和原创性等,对稿件进行综合评估。尽管任何机构均无法保证每篇稿件都会被发表,但我们可以用专业知识和丰富经验,协助您理解并遵循期刊的发表要求,从而提高您的稿件被发表的机率。
期刊发表的费用因期刊不同而异。根据您的需求,我们会为您推荐性价比最高的期刊,并提供专业的期刊供您选择。一般来说,只要符合职称要求,大多数作者都会选择性价比最高的期刊作为意向期刊进行重点咨询。我们会为您提供详细的期刊信息和费用说明,以确保您能够做出明智的选择。
一般来说,我们推荐的期刊和您的专业方向、文章情况都是匹配的,极少出现稿件被拒的情况。如果稿件被拒,期刊编辑会提供详细的拒稿信和建议,以帮助您了解拒稿原因并改进您的稿件。关于退款政策,具体情况可能因期刊不同而异,请您咨询我们的工作人员以获取详细信息。
中科院 4区 JCR Q2
大类:医学
中科院 4区 JCR Q3
大类:医学
中科院 4区 JCR Q3
大类:医学
中科院 4区 JCR Q2
大类:医学
中科院 3区 JCR Q1
大类:医学
中科院 4区 JCR Q1
大类:医学
中科院 2区 JCR Q1
中科院 3区 JCR Q1
中科院 1区 JCR Q1
中科院 1区 JCR Q1
中科院 4区 JCR Q2
中科院 3区 JCR Q2
中科院 4区 JCR Q1
中科院 4区 JCR Q2